Image-empty-state.png

Sunil Gairola

Executive Director
Serum Institute of India Pvt. Ltd


Sunil Gairola, Ph.D, is the Executive Director of Serum Institute of India Pvt. Ltd. He has more than 38 years of experience in quality control of vaccines, adjuvant development, and managing quality control-related activities, and has significantly contributed towards the development and calibration of national reference Standards for vaccines and antisera. Expertise in characterization of bacterial, viral, recombinant antigens and biosimilars using advanced analytical tools and implementation of newer technologies in quality control of vaccines. Collaborator to international initiatives of WHO, NVI, NIBSC, EDQM, and PATH, aimed at the harmonization of regulatory requirements, the establishment of international standards, and the development of quality control release assays for immunobiologicals. Served as IP Expert committee for many years and Member, Scientific Body. He is also member to expert committee/panel of USP. Published research papers in National and International journals. Attended many National and International Conferences as well as WHO Consultations on scientific topics.

123-456-7890